Listen to this text  |
Versius surgical robotics programs. | Source: CMR Surgical
CMR Surgical Ltd. this week introduced that it closed 2023 with a report variety of Versius surgical robotic installations in a single quarter.
Founded in 2014, CMR Surgical stated it closed the 12 months with its Versius international set up base greater than 50% larger than in 2022. The Cambridge, U.Ok.-based firm reported greater than 17,000 procedures accomplished with the surgical robotic throughout the 12 months for progress of greater than 60%.
Versius is a small-scale surgical robotic that includes collaborative arms and bedside models for direct affected person entry. It additionally options presents of port placement to finest swimsuit the wants of every affected person, stated CMR Surgical in a launch.
It designed Versius to allow surgeons to carry out extra minimally invasive procedures. The robotic assists surgeons accessing the lungs, thymus, and esophagus.
Surgeons worldwide efficiently use Versius
“Our staff are skilled in doing complicated urological robotic assisted surgical procedures for a few years, and from the primary 100 circumstances utilizing Versius, I can say that switching from the surgical robotic we have been beforehand utilizing to a Versius robotic proved very straightforward and extra environment friendly in a number of respects,” commented Thierry Rousseau, president of the Medical Committee at Clinique Urologique Nantes-Atlantis.
“The versatility of Versius has enabled us to carry out complicated procedures corresponding to prostatectomies with ease, enabling us to adapt the surgical robotic into our current surgical apply with simplicity,” he stated.
Expansion over 2023 included new markets corresponding to Greece and Indonesia. In addition, CMR Surgical raised $165 million in September to help Versius.
Recent highlights embody the newest Versius set up in Germany, famous CMR. There have been greater than 140 around the globe thus far.
CMR Surgical goals to speed up robotic adoption
CMR Surgical stated it plans to launch new applied sciences to additional help the utilization of Versius in 2024. These applied sciences embody imaginative and prescient, instrumentation, and digital enhancements. The firm asserted that it goals to enter extra new markets throughout the coming 12 months.
New Chief Commercial Officer Massimiliano Colella is charged with main the additional acceleration of Versius installations, stated CMR Surgical.
“As we enter our fifth 12 months for the reason that launch of Versius, this can be a tremendously thrilling time for CMR and our clients as we see the momentum for Versius, and robotic-assisted surgical procedure develop exponentially,” acknowledged Supratim Bose, CEO of CMR Surgical.
“Versius is a really differentiated product that’s serving to extra hospitals around the globe provide robotic-assisted surgical procedure,” he declared. “Additionally, the launch of latest superior applied sciences for Versius – throughout each {hardware} and software program – might be a game-changer this 12 months.
“We are already seeing Versius show its use in complicated surgical procedures, and with new merchandise available on the market, we look ahead to working with our clients to develop the procedures which can be carried out utilizing Versius, and welcome new hospitals in current and new geographies, in order that extra sufferers can profit from robotic-assisted surgical procedure,” Bose stated.
Editor’s observe: This article was syndicated from MassDevice, a sibling web site to The Robot Report.
